Weighing Dose‐Related Benefits and Risks of Hydroxychloroquine Treatment in Patients With Systemic Lupus Erythematosus
Objective To weigh higher‐dose hydroxychloroquine (HCQ; ≥400 mg/day) and lower‐dose HCQ (<400 mg/day) for effectiveness and safety among patients with systemic lupus erythematosus (SLE). Methods This nationwide study retrieved data from Taiwan's National Health Insurance Researc…